Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by RomaJoy


SAVEQ

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

TOPS

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

SBUX

Kevin Harrington Discusses FSD Pharma

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 13, 2023

SBUX

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 14, 2022

TOPS

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 14, 2022

SAVEQ

FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent

  FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On...

July 14, 2022

SAVEQ

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

TOPS

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

SBUX

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

June 3, 2022

SBUX

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 1, 2022

TOPS

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 1, 2022

SAVEQ

FSD Pharma Files Investigational New Drug Application “IND”

  FSD Pharma Files Investigational New Drug Application (“IND”) with...

June 1, 2022

SBUX

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 10, 2022

TOPS

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 10, 2022

SAVEQ

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

  FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets   ...

May 10, 2022

SBUX

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 3, 2022

TOPS

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

May 1, 2022

SAVEQ

Lucid-MS for Multiple Sclerosis Treatment

{^youtubevideo|(width)560|(height)340|(rel)False|(url)https://www.youtube.com...

April 30, 2022

SBUX

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 25, 2022

TOPS

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

FSD Pharma Appoints Julia Levy Award Recipient David Allan and Dr. John...

April 24, 2022

1 2 Next

Featured Company